These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4933388)

  • 1. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.
    Howard AN; Hyams DE
    Br Med J; 1971 Jul; 3(5765):25-7. PubMed ID: 4933388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
    Evans RJ; Howard AN; Hyams DE
    Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of essential hyperlipidaemia.
    Fredrickson DS; Levy RI
    Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Acta Med Scand; 1977; 202(3):179-81. PubMed ID: 333869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
    Howard AN; Hyams DE; Evans C
    Adv Exp Med Biol; 1972; 26(0):179-87. PubMed ID: 4679724
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
    Faergeman O
    Acta Med Scand; 1973; 194(3):165-7. PubMed ID: 4746523
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 11. An effective treatment of hypercholesterolaemia. Use of a combination of a bile acid sequestrant and clofibrate.
    Howard AN; Evans RJ; Hyams DE
    Med Chir Dig; 1972; 1(5):235-9. PubMed ID: 4631445
    [No Abstract]   [Full Text] [Related]  

  • 12. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
    Fedele F
    Clin Ter; 2003; 154(4):231-6. PubMed ID: 14618939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE
    Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesteryl ester turnover in human plasma lipoproteins during cholestyramine and clofibrate therapy.
    Goodman DS; Noble RP
    J Lipid Res; 1970 May; 11(3):183-9. PubMed ID: 5441241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthomatosis associated with hyperlipoproteinemia.
    Parker F; Short JM
    J Invest Dermatol; 1970 Aug; 55(2):71-88. PubMed ID: 4923080
    [No Abstract]   [Full Text] [Related]  

  • 18. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Artery; 1982; 10(5):353-67. PubMed ID: 7181678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].
    Richter WO
    Fortschr Med; 1996 May; 114(14):177-8. PubMed ID: 8707237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.